Total Voting Rights

/**/

RNS Number : 1927N Frontier IP Group plc 31 December 2025  

31 December 2025   Frontier IP Group plc ("Frontier IP", the "Company" or the "Group")   Total Voting Rights   Frontier IP Group plc (AIM: FIPP), a specialist in commercialising intellectual property, announces that the issued share capital of the Company at the date of this announcement comprises 75,638,239 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury, therefore the total number of Ordinary Shares and voting rights in the Company is 75,638,239.   The above figure of 75,638,239 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.   ENQUIRIES  

Frontier IP Group Plc Neil Crabb, Chief Executive   Andrew Johnson, Communications & Investor Relations Company website: www.frontierip.co.uk  

  neil@frontierip.co.uk   M: 07464 546 025 andrew.johnson@frontierip.co.uk  

Allenby Capital Limited (Nominated Adviser) Nick Athanas  

T: 0203 328 5656

Singer Capital Markets (Broker) Charles Leigh-Pemberton / James Fischer

T: 0207 496 3000  

  ABOUT FRONTIER IP Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs. The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  TVRBLBDDCDXDGUG